ID   M25K
AC   CVCL_8105
DR   Cosmic; 733830
DR   IARC_TP53; 23634
DR   Wikidata; Q54903571
RX   CelloPub=CLPUB00243;
RX   PubMed=1568228;
RX   PubMed=11251971;
RX   PubMed=11283936;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: No history of asbestos exposure (PubMed=1568228).
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
RX   CelloPub=CLPUB00243;
RA   Kahlos K.;
RT   "The expression and possible role of manganese superoxide dismutase in
RT   malignant pleural mesothelioma.";
RL   Thesis PhD (1999); University of Oulu; Oulu; Finland.
//
RX   PubMed=1568228;
RA   Metcalf R.A., Welsh J.A., Bennett W.P., Seddon M.B., Lehman T.A.,
RA   Pelin-Enlund K., Linnainmaa K., Tammilehto L., Mattson K., Gerwin B.I.,
RA   Harris C.C.;
RT   "p53 and Kirsten-ras mutations in human mesothelioma cell lines.";
RL   Cancer Res. 52:2610-2615(1992).
//
RX   PubMed=11251971; DOI=10.1002/1097-0215(200002)9999:9999<::AID-IJC1094>3.0.CO;2-M;
RA   Kettunen E., Nissen A.-M., Ollikainen T., Taavitsainen M., Tapper J.,
RA   Mattson K., Linnainmaa K., Knuutila S., El-Rifai W.;
RT   "Gene expression profiling of malignant mesothelioma cell lines: cDNA
RT   array study.";
RL   Int. J. Cancer 91:492-496(2001).
//
RX   PubMed=11283936; DOI=10.1002/1097-0142(20010401)91:7<1349::AID-CNCR1138>3.0.CO;2-D;
RA   Kahlos K., Soini Y., Sormunen R., Kaarteenaho-Wiik R., Paakko P.,
RA   Linnainmaa K., Kinnula V.L.;
RT   "Expression and prognostic significance of catalase in malignant
RT   mesothelioma.";
RL   Cancer 91:1349-1357(2001).
//